Generic Name and Formulations:
Minoxidil 2%; 5%; topical soln; contains alcohol.
McNeil Consumer Healthcare
Indications for ROGAINE:
Apply 1mL to scalp twice daily. Women: use 2% strength only.
Do not use on abraded or inflamed scalp. Discontinue if systemic effects occur. Avoid eyes, mucous membranes or inhalation. Reevaluate if no improvement after 4 months. Cardiac disease. Pregnancy, nursing mothers: not recommended.
Do not use with other topical agents. Additive effects with guanethidine, other antihypertensives.
Soln (60mL)—1, 3
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies